AI-assisted, human-published
05/27/2025 /Funding Events
Pillar Biosciences Secures $34.5 Million Funding for Decision Medicine Advancements
Pillar Biosciences secures $34.5 million in funding, with a strategic investment from Illumina and structured financing from Soleus Capital. The company specializes in Decision Medicine, using next-generation sequencing (NGS) testing technology to optimize personalized therapies for cancer patients.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com